Patent · US Active

Anti-IL-23 antibodies

US9441036B2 · kind B2 · utility

6Cited by

37References

14Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Rachel Rebecca Barrett · Bethel, US
Keith Canada · Southbury, US
Katrina Mary Catron · Middlebury, US
Robert Copenhaver · Portland, US
Lee Edward Frego · Hopewell Junction, US
Ernest Lee Raymond · New Milford, US
Sanjaya Singh · Sandy Hook, US
Xiangyang Zhu · Lo Wu, CN

Key dates

Filing date	Jun 12, 2014
Grant date	Sep 13, 2016
Priority date	—
Expiry date	Aug 1, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.